News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,480 Results
Type
Article (87523)
Company Profile (807)
Press Release (774128)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233090)
Career Advice (4140)
Deals (39809)
Drug Delivery (140)
Drug Development (91279)
Employer Resources (203)
FDA (18296)
Job Trends (17407)
News (397479)
Policy (39929)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56980)
ALS (147)
Alzheimer's disease (1690)
Antibody-drug conjugate (ADC) (262)
Approvals (18330)
Artificial intelligence (513)
Autoimmune disease (99)
Automation (29)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (520)
Cancer (4135)
Cardiovascular disease (359)
Career advice (3562)
Career pathing (38)
CAR-T (256)
CDC (57)
Cell therapy (708)
Cervical cancer (33)
Clinical research (75770)
Collaboration (1440)
Company closure (4)
Compensation (955)
Complete response letters (62)
COVID-19 (2962)
CRISPR (85)
C-suite (616)
Cystic fibrosis (141)
Data (4860)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (462)
Diagnostics (7103)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (244)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (207)
Earnings (99118)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133391)
Executive appointments (998)
FDA (20867)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1295)
Gene editing (180)
Generative AI (52)
Gene therapy (562)
GLP-1 (1033)
Government (5391)
Grass and pollen (8)
Guidances (372)
Healthcare (20939)
HIV (49)
Huntington's disease (41)
IgA nephropathy (64)
Immunology and inflammation (255)
Immuno-oncology (22)
Indications (59)
Infectious disease (3212)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (197)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10150)
Liver cancer (92)
Longevity (13)
Lung cancer (591)
Lymphoma (285)
Machine learning (33)
Management (66)
Manufacturing (669)
MASH (145)
Medical device (14906)
Medtech (14932)
Mergers & acquisitions (22777)
Metabolic disorders (1181)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (236)
Neuropsychiatric disorders (63)
Neuroscience (2759)
NextGen: Class of 2025 (7687)
Non-profit (5097)
Now hiring (60)
Obesity (569)
Opinion (316)
Ovarian cancer (140)
Pain (172)
Pancreatic cancer (176)
Parkinson's disease (245)
Partnered (32)
Patents (428)
Patient recruitment (334)
Peanut (57)
People (66347)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23371)
Phase II (32876)
Phase III (24798)
Pipeline (2834)
Policy (302)
Postmarket research (3554)
Preclinical (10549)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (705)
Real estate (7422)
Recruiting (79)
Regulatory (28118)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (160)
Service/supplier (30)
Sickle cell disease (84)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1061)
Venture capital (68)
Weight loss (403)
Women's health (60)
Worklife (21)
Date
Today (192)
Last 7 days (848)
Last 30 days (2971)
Last 365 days (33588)
2025 (28016)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (308)
Arkansas (14)
Asia (51064)
Australia (8977)
California (9799)
Canada (2922)
China (944)
Colorado (414)
Connecticut (434)
Delaware (281)
Europe (117341)
Florida (1437)
Georgia (323)
Hawaii (3)
Idaho (67)
Illinois (827)
India (55)
Indiana (481)
Iowa (20)
Japan (337)
Kansas (127)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1308)
Massachusetts (7334)
Michigan (318)
Minnesota (581)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2719)
New Mexico (32)
New York (2650)
North Carolina (1432)
North Dakota (10)
Northern California (4492)
Ohio (308)
Oklahoma (22)
Oregon (51)
Pennsylvania (2025)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3737)
Tennessee (153)
Texas (1539)
United States (36050)
Utah (297)
Virginia (253)
Washington D.C. (84)
Washington State (836)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
There are 862,480 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
November 4, 2025
·
5 min read
Press Releases
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
November 4, 2025
·
6 min read
Press Releases
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
November 4, 2025
·
7 min read
Press Releases
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 4, 2025
·
6 min read
Press Releases
Kura Oncology and Kyowa Kirin Announce Presentations of Ziftomenib Ven/Aza Combination Data in Frontline and Relapsed/Refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia at 2025 ASH Annual Meeting
November 4, 2025
·
5 min read
Press Releases
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
November 4, 2025
·
11 min read
Press Releases
Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025
November 4, 2025
·
1 min read
Press Releases
Syndax Announces Compelling Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Data Accepted for Presentation at ASH 2025
November 4, 2025
·
22 min read
Press Releases
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
November 4, 2025
·
8 min read
Press Releases
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
November 4, 2025
·
10 min read
1 of 86,248
Next
